InnoCare Pharma Limited (HKG:9969)
10.84
+0.49 (4.73%)
Jun 18, 2026, 4:08 PM HKT
InnoCare Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Upgrades $19.60 → $17.00 | Buy | Upgrades | $19.60 → $17.00 | +56.83% | May 28, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $19.40 | Buy | Maintains | $19.40 | +78.97% | May 14, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $11.95 → $18.31 | Buy | Maintains | $11.95 → $18.31 | +68.91% | Apr 24, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $19.80 → $21.40 | Buy | Maintains | $19.80 → $21.40 | +97.42% | Apr 23, 2026 |
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $16.81 | Buy | Maintains | $16.81 | +55.07% | Dec 25, 2025 |